Udaya Valluri Selected Research

Chronic Renal Insufficiency

3/2022	Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES).
10/2021	Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).
1/2021	Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES).
1/2021	Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Udaya Valluri Research Topics

Disease

4	Chronic Renal Insufficiency 03/2022 - 01/2021
3	Hypoxia (Hypoxemia) 10/2021 - 01/2021
2	Anemia 10/2021 - 01/2021
1	Endometrial Hyperplasia 01/2023
1	Neoplasms (Cancer) 01/2023
1	Hot Flashes 01/2023
1	Chemical and Drug Induced Liver Injury 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Rheumatoid Arthritis 09/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2018

Drug/Important Bio-Agent (IBA)

4	roxadustatIBA 03/2022 - 01/2021
3	Prolyl-Hydroxylase InhibitorsIBA 10/2021 - 01/2021
1	fezolinetantIBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Alkaline PhosphataseIBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	BilirubinIBA 01/2023
1	EnzymesIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	oxidized low density lipoproteinIBA 01/2021
1	IronIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	peficitinibIBA 09/2020
1	Methotrexate (Mexate)FDA LinkGeneric 09/2020
1	Janus Kinase InhibitorsIBA 09/2020
1	bleselumabIBA 05/2018
1	Syntex adjuvant formulationIBA 05/2018